Definitive Healthcare (DH) Cash from Restructuring (2024 - 2025)
Definitive Healthcare (DH) reported Cash from Restructuring of $243000.0 for Q4 2025, up 26.56% on a YoY basis from $192000.0 in Q4 2024, and up 51.88% quarter-over-quarter from $160000.0 in Q3 2025.
Definitive Healthcare (DH) Cash from Restructuring (2024 - 2025) Analysis & Trends
Definitive Healthcare has reported Cash from Restructuring for 2 years, with the latest figure at $243000.0 in Q4 2025.
- For the quarter ending Q4 2025, Cash from Restructuring rose 26.56% year-over-year to $243000.0; the trailing twelve-month figure through Mar 2026 stood at $403000.0 (down 71.84% YoY), and the FY2025 full-year result was $595000.0, down 51.98% from the prior year.
- Cash from Restructuring for Q4 2025 stood at $243000.0, up from $160000.0 in the prior quarter.
- The five-year high for Cash from Restructuring was $1.0 million in Q2 2024, with the low at $160000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Veeva Systems | 24.83 Bn | 17.52 Bn | 662.02 Mn |
| 2 | BrightSpring Health Services | 13.57 Bn | 12.69 Bn | 482.22 Mn |
| 3 | Healthequity | 7.20 Bn | 6.93 Bn | 256.31 Mn |
| 4 | Hinge Health | 5.42 Bn | 5.11 Bn | 154.23 Mn |
| 5 | 10x Genomics | 4.46 Bn | 3.92 Bn | 106.18 Mn |
| 6 | Doximity | 3.81 Bn | 3.06 Bn | 125.97 Mn |
| 7 | Waystar Holding | 3.52 Bn | 3.36 Bn | 268.04 Mn |
| 8 | Privia Health | 2.94 Bn | 2.57 Bn | 595.71 Mn |
| 9 | Omnicell | 1.76 Bn | 1.59 Bn | 140.36 Mn |
| 10 | Definitive Healthcare | 82.10 Mn | -31.13 Mn | 41.65 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 243,000.00 |
| Sep 30, 2025 | 160,000.00 |
| Mar 31, 2025 | 192,000.00 |
| Dec 31, 2024 | 192,000.00 |
| Jun 30, 2024 | 1.05 Mn |